Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
07/2002
07/24/2002CN1360574A Process for preparation of tricyclic amino alcohol derivs.
07/24/2002CN1088061C Dihalopropene compounds, insecticidal/acaricidal agent contg. same, and intermediates
07/23/2002US6423870 Tricyclic compounds, preparation method and pharmaceutical compositions containing same
07/23/2002US6423842 Act preferentially on m4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; alzheimer's disease; cognition activators.
07/23/2002US6423740 Chalcones having antiproliferative activity
07/23/2002US6423729 Therapeutic or prophylactic agent for glomerulopathy
07/23/2002US6423727 Certain thiol inhibitors of endothelin-converting enzyme
07/23/2002US6423717 Nervous system disorders
07/23/2002US6423691 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytography
07/23/2002US6423676 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same
07/18/2002WO2002055609A2 Indole/indoline based hybrid dyes and indole/indoline based hybrid dye intermediate products
07/18/2002WO2002055517A2 4-(hetero)aryl substituted indolinones
07/18/2002WO2002055492A2 An improved process for preparing pure ondansetron hydrochloride dihydrate
07/18/2002WO2002055485A1 Prodrugs of excitatory amino acids
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/18/2002WO2002016310A9 Selective androgen receptor modulators and methods of use thereof
07/18/2002WO2002002556A3 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS
07/18/2002WO2001096299A3 Indole derivatives and their use as 15-lipoxygenase inhibitors
07/18/2002WO2001081307A3 Triaryl cation antibiotics from environmental dna
07/18/2002WO2001074487A9 Method of separating imide compound
07/18/2002WO2001072685A3 Polyamine analogues as cytotoxic agents
07/18/2002WO2001056974A3 Inha inhibitors and their use as antibacterials
07/18/2002US20020095056 Hydrogenation of an imine in the presence of a base and, a ruthenium complex of a chiral diphosphine and diamine catalyst
07/18/2002US20020095054 Process to produce oxazolidinones
07/18/2002US20020095044 Substituted isoindolinone derivatives
07/18/2002US20020095043 Reducing a nitro-substituted 3-azabicyclo(3.1.0)hexane compound in the presence of iron and an organic solvent under acidic conditions and acylating the product
07/18/2002US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias
07/18/2002US20020094989 Pyrrolidine modulators of CCR5 chemokine receptor activity
07/18/2002CA2433720A1 An improved process for preparing pure ondansetron hydrochloride dihydrate
07/18/2002CA2432114A1 4-(hetero)aryl substituted indolinones
07/17/2002EP1223196A2 Negative image-recording material and cyanine dye
07/17/2002EP1222168A2 Slurry preparation of bis(halophthalimides) and of polyether polymers
07/17/2002EP1222167A2 Method for producing indole derivatives on a solid phase
07/17/2002EP1073440A4 sPLA 2 INHIBITOR ESTER
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/16/2002US6420424 CCR-3 receptor antagonists
07/16/2002US6420415 Thiol compounds, their production and use
07/16/2002US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same
07/16/2002US6420413 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds
07/16/2002US6420408 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
07/16/2002US6420363 Mono- or polyenic carboxylic acid derivatives
07/16/2002US6420341 Treating vasoconstrictor and hypertension effects in warm-blooded animals
07/16/2002US6420316 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
07/16/2002US6420188 Screening assay for the identification of inhibitors for macrophage migration inhibitory factor
07/16/2002CA2104452C Treatment of cellulite with retinoids
07/11/2002WO2002053535A2 Process for making amlodipine, derivatives thereof, and precursors therefor
07/11/2002WO2002053534A1 Vla-4 inhibitors
07/11/2002WO2002053135A1 Amlodipine free base
07/11/2002WO2002024632A3 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
07/11/2002WO2002017914A8 Fused pyrrolocarbazoles against inflammation
07/11/2002WO2000073263A9 Cytofectin dimers and methods of use thereof
07/11/2002US20020091271 Reacting a 3-chloro-3- carboxylate indole compound with 3-chloropropanol in presence of trichloroacetic acid to form methyl 2-(3-chloropropoxy)-indole-3-carboxylate
07/11/2002US20020091148 3-substituted indole antiproliferative angiogenesis inhibitors
07/11/2002US20020091124 Also used as an antimitotic and for direct and/or indirect inhibition of tubulin polymerization in mammalian
07/11/2002US20020091115 Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
07/11/2002US20020091090 Somatostatin antagonists and agonists
07/11/2002US20020091089 (Substituted)acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases
07/11/2002US20020090728 High-throughput screening for the detection of preferential reaction products; obtain sample, monitor enantiomeric ratios, absolute configuration and percent conversion for preferential products
07/11/2002DE10100938A1 Indol-/Indolin-Hybridfarbstoffe und -hybridfarbstoffvorprodukte Indole / indoline hybrid dyes and -hybridfarbstoffvorprodukte
07/11/2002DE10061162A1 Aryl-substituierte Indirubinderivate, deren Herstellung und Verwendung Aryl substituted indirubin derivatives, their preparation and use
07/10/2002EP1221441A2 LTA4 Hydrolase inhibitors
07/10/2002EP1220841A2 Trifluoromethyl-substituted spirocyclic ketoenols
07/10/2002EP1220840A2 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
07/10/2002EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
07/10/2002EP1220836A2 Benzylcycloalkyl amines as modulators of chemokine receptor activity
07/10/2002EP1220832A1 Novel aromatic compounds
07/10/2002CN1357540A Fluorescent reagent 2-(N-carbazyl)-chlorethyl formate
07/10/2002CN1357539A Synthesis of indolyl-3-acetamide
07/10/2002CN1357327A Carbazolyl alkaloid anticarcinogen and its prepn
07/10/2002CN1087294C Novel compounds
07/10/2002CN1087283C New LH-RH antigonists with improved effectiveness
07/09/2002US6417387 α-and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
07/09/2002US6417370 Arylphenyl-substituted cyclic keto-enols
07/09/2002US6417362 Piperazine derivatives; arteriosclerosis, pancreatitis, and cardiovascular disorder treatment; side effect reduction
07/09/2002US6417214 Compounds as contraceptives
07/09/2002US6417200 Antithrombotic agents
07/09/2002CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them
07/09/2002CA2041224C Azatetracycle compounds
07/09/2002CA2036307C 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
07/04/2002WO2002051833A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
07/04/2002WO2002051813A2 PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES
07/04/2002WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
07/04/2002WO2002051805A1 Indole derivatives as ligands of thyroid receptors
07/04/2002WO2002051396A1 Pharmaceutical compositions containing cyclobutene derivatives
07/04/2002WO2002038543A3 3-substituted oxindole beta 3 agonists
07/04/2002WO2002028347A3 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
07/04/2002WO2002022576A3 3-substituted indole carbohydrazides useful as cell proliferation and angiogenesis inhibitors
07/04/2002WO2002003991A3 Use of substituted indole compounds for increasing nitric oxide synthase activity
07/04/2002US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates
07/04/2002US20020086887 N-Acylsulfonamide apoptosis promoters
07/04/2002US20020086874 Substituted indoline derivative compounds which are antagonists of the progesterone receptor; contraceptives; antineoplastic agents
07/04/2002US20020086860 For treatment or prevention of disorders such as obsessive-compulsive disorder, depression, anxiety, schizophrenia
07/04/2002CA2668823A1 Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
07/04/2002CA2433100A1 Indole derivatives as ligands of thyroid receptors
07/04/2002CA2433089A1 Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
07/04/2002CA2432473A1 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
07/04/2002CA2432008A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands
07/03/2002EP1220024A2 Silver halide photographic element
07/03/2002EP1219604A1 Method for improving the solubility of tricyclic amino alcohol derivatives
07/03/2002EP1219294A1 Melanin concentrating hormone antagonists